
Investors & Media
Investors & Media
- Overview
- News Releases
- Events & Presentations
- Stock Information
- Corporate Governance
- Financial Information
- Investor Resources
Stockholder Tools
News Releases
News Releases
December 16, 2020
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
November 30, 2020
MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
November 23, 2020
MeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 19, 2020
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
November 18, 2020
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
November 13, 2020
MeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After Treatment
November 10, 2020
MeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit
November 5, 2020
MeiraGTx Reports Third Quarter 2020 Financial Results
October 28, 2020
MeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting
October 3, 2020
MeiraGTx Announces Nine-Month Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant and Sustained Vision Improvement in X-Linked Retinitis Pigmentosa (XLRP)
Displaying 1 - 10 of 21
Investors & Media
- Overview
- News Releases
- Events & Presentations
- Stock Information
- Corporate Governance
- Financial Information
- Investor Resources